Premium
Letter: which patients with hepatitis B virus‐related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy?
Author(s) -
Liao Y.Y.,
Ahir B.K.,
Mo H.Y.,
Li L.Q.,
Peng N.F.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13773
Subject(s) - medicine , hepatocellular carcinoma , hepatitis b virus , gastroenterology , population , hepatitis b , oncology , virus , virology , environmental health